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http:WHAT THIS PAPER ADDS
This study found a profound lack of awareness of peripheral artery disease consistent with the ﬁndings of
previous large international studies. It provides further evidence that focused awareness campaigns should
address this paucity of knowledge to match patient and public knowledge of heart disease and stroke.Objectives: Patients with symptomatic peripheral artery disease (PAD) have a 30% risk of death within 5 years.
However, public awareness of vascular disease has been shown to be low. The aim of this study was to assess
awareness regarding risk factors, signiﬁcance and potential sequelae of PAD in an Irish population.
Design: A cross-sectional, anonymous survey of patients and members of the public.
Materials: An anonymous questionnaire was developed to collect details on basic demographics, presence of and
treatment for risk factors for cardiovascular disease, awareness of PAD and its risk factors and sequelae. The local
ethics committee granted ethical approval.
Methods: Two investigators in face-to-face interviews administered the survey with patients and members of the
general public, older than 40 years of age, attending a range of outpatient clinics, day care services and in
patients.
Results: A total of 336 questionnaires were administered. A post-secondary school course had been completed
by 32% of respondents. Only 19% of patients reported familiarity with PAD, a ﬁgure considerably lower than
those reporting familiarity with stroke (94%), coronary artery disease (78%) or diabetes (98%) (Chi Squared
p<0.001). The only independent predictor of awareness of PAD was having a post-secondary school course with
an odds ratio or 4.2.
Conclusions: This study demonstrates a disturbing lack of awareness of PAD and highlight the need for a
meaningful targeted public health awareness campaign on PAD in order to close the gap of knowledge in Irish
patients, prior to any prevention campaign.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Atherothrombosis, which includes peripheral artery disease
(PAD), coronary artery disease, and cerebral artery disease,
is the number one cause of mortality in the world.1,2 PAD is
a recognized marker of generalized atherosclerosis. It is
associated with signiﬁcant overall mortality, 30% within 5
years and 50% at 10 years, primarily from myocardial
infarction or stroke.3e5 The 5-year survival probability for
people with an ankle brachial index (ABI) less than 0.4 and
critical ischaemia is only 56%.6 This is less than patients who
have suffered stroke (70%), coronary heart disease (79%),
and some cancers such as breast cancer (85%).7,8of original article: http://dx.doi.org/10.1016/j.ejvs.2015.01.015
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//dx.doi.org/10.1016/j.ejvs.2014.12.017PAD, however, remains under-recognised, under-
diagnosed, and undertreated. Approximately half of pa-
tients with PAD are asymptomatic, with typical symptoms
present in only 20%.9 This may contribute to its under-
recognition in primary practice.
Despite the high prevalence and associated mortality risk
with PAD,7 no meaningful awareness campaign has been
initiated in Ireland. Previous studies in North America and
Holland have demonstrated poor public knowledge of
PAD.2,4,10,11 Initiatives such as the “Legs for Life” US
screening programme have used a combination of risk
assessment form and ABI to identify patients with PAD. This
intervention by the Society of Interventional Radiology
began in 1997 and was deemed successful in the short
term, although no subsequent studies have been published
to report longer-term outcomes such as mortality or rate of
lower limb amputation.13
The aim of this study was to assess both awareness of
and attitudes to PAD among a general population, including
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sequelae of the disease.MATERIALS AND METHODS
This cross-sectional, tertiary hospital-based, descriptive
study was conducted between December 1, 2012, and April
21, 2013. An anonymous questionnaire was designed which
assessed basic demographics, the presence of risk factors
and current treatment for cardiovascular disease and dia-
betes, self-reported knowledge of a range of diseases
including PAD and other vascular and non-vascular diseases.
The questionnaire is presented in full in the Electronic
Supplementary Material, Fig. 1. Level of education
completed was assessed based on whether or not a post-
secondary-school degree or diploma course was completed.
Prior to commencing the study, a pilot trial of the
questionnaire was performed on 20 individuals, after which
only minor edits were required. The local ethics committee
granted ethical approval for administration of the ques-
tionnaire and study.
The questionnaire was administered in hospital by two
investigators (C.C., D.M.C.) in face-to-face interviews. Pa-
tients and members of the general public over 40 years of
age were invited to participate in a range of settings
including clinics in general/vascular surgery, nephrology and
endocrinology, day care services and general surgery, and
medical and orthopaedic inpatient wards. Members of the
public who were accompanying patients at the same clinical
settings, but were not attending hospital for their own
beneﬁt, were also invited. Two hundred and sixteen of the
cohort were patients and 120 were members of the public.
The purpose of the survey was verbally explained with a
supporting pamphlet and informed consent was obtained
from all those who agreed to participate. Only two people
invited to participate refused to partake in the study. All
participants completed the administered questionnaire
process. Exclusion criteria included practising medical
personnel and people under the age of 40.
Participants who were unfamiliar with the terms PAD
were provided with an explanation as “disease of the ar-
teries of the legs, a blockage or a narrowing of the arteries,
affecting the circulation” before proceeding to subsequent
questions. This conﬁrmed an absence of awareness of PAD
and was recorded as such on the questionnaire. Participant
awareness at a minimal level was deﬁned by participant
familiarity with the term and knowledge of the organ it
affected. For PAD we accepted participant awareness if they
cited that it was a problem affecting either the “arteries” or
the “circulation” of the legs.
Statistical analyses were carried out using MINITAB
software. Data are reported as percentages. Chi-square ta-
bles were used for comparison of categorical data. The two-
sample Student t test or the ManneWhitney U test was
used for continuous variables depending on data normality.
Multivariate logistic regression analysis was used to ascer-
tain independent predictors for an increased awareness of
PAD. The variables included were age >60 years, level ofpost-secondary-school education, presence of diabetes,
treatment for either hypertension or hyper-
cholesterolaemia, sex, smoking status, and a history of
treatment for stroke or myocardial infarction. Statistical
signiﬁcance was set at p < .05.RESULTS
A total of 336 surveys were administered during the study
period to 165 (49%) men and 171 (51%) women, with 48%
of participants aged over 60 (Table 1). Almost one-third of
participants had completed a post-secondary-school course,
diploma, or degree. The prevalence of smoking in re-
spondents was 17%, with a further 40% reporting a past
history of smoking.
Forty-one per cent reported receiving treatment for hy-
pertension and 35% for hypercholesterolaemia. People
treated for diabetes were over-represented, accounting for
20% of the study group. Thirteen per cent reported a past
myocardial infarction and 8% reported a previous stroke.
Men had a higher prevalence of diabetes, past history of
smoking, and treatment for previous cardiovascular disease
(Table 2). There was an increased presence of all risk factors
in patients over the age of 60. Respondents with a lower
level of education had almost double the risk factors for
hypertension, hypercholesterolaemia, and diabetes. One
hundred and ten (32%) respondents reported current leg
symptoms, including 39 (11%) describing frequent pain on
walking and 21 (6.25%) reporting frequent pain when
sitting.
The study population demonstrated a high awareness of
stroke (94%), coronary artery disease (78%), diabetes (98%),
and bowel cancer (86%) (Table 3). In contrast, only 19% self-
reported awareness of PAD and 26% were aware of
abdominal aortic aneurysm (AAA). Awareness of both PAD
and AAA was greater in those with post-secondary-school
education but no variation with age was noted. Although
incidence of AAA is greater in men, in this population self-
reported awareness of AAA was greater in women. There
was no difference in rates of awareness of PAD in those
who were current or ex-smokers when compared with
those who had never smoked (17% vs. 22%, p ¼ .260).
The majority of respondents (86%) correctly identiﬁed
smoking as being high risk for development of PAD
(Table 4). However, they similarly cited obesity (79%), lack
of exercise (80%), and alcohol (68%) as high risk. Overall,
68% of respondents cited diabetes as a potential risk factor
for PAD with a higher acknowledgement of diabetes as a
risk factor by those with diabetes (82%) than those without
(64%) (p ¼ .005).
When questioned on the perceived consequences of PAD
if not treated, similar to the responses for risk factors, there
was little ability to differentiate the speciﬁc sequelae (chi
square 2  6 table, p ¼ 1.000) for PAD (Table 5). Ampu-
tation was recognized as a potential consequence by 60% of
respondents, with those older than 60 years attributing a
higher risk of PAD leading to all listed outcomes than
younger respondents. Participants who felt themselves
Table 1. Basic demographics of questionnaire respondents.
All respondents
(n ¼ 336)
Patients
(n ¼ 216)
Members of
public (n ¼ 120)
p-Value
(chi-square)
Population
estimates for
risk factors
Sex Male 165 (49%) 107 (50%) 58 (48%) 0.833 49%a,14
Female 171 (51%) 109 (50%) 62 (52%) 51%
Age 40e49 100 (30%) 66 (31%) 34 (28%) 0.669 33%a,14
50e59 75 (22%) 47 (22%) 28 (23%) 0.740 27%
60e69 65 (19%) 43 (20%) 22 (18%) 0.726 21%
70e79 64 (19%) 38 (18%) 26 (22%) 0.362 12%
>80 32 (10%) 22 (10%) 10 (8%) 0.580 7%
Post-secondary-course
completion
Yes 107 (32%) 73 (34%) 34 (28%) 0.303 33%b,15
No 229 (68%) 143 (66%) 86 (72%) 67%
Smoking Current 58 (17%) 37 (17%) 21 (18%) 0.931 29%16
Ex-smoker 135 (40%) 87 (40%) 48 (40%) 0.960 19%17
Never smoked 143 (43%) 92 (43%) 51 (42%) 0.987 52%
Cardiovascular risk factors Diabetes 67 (20%) 41 (19%) 26 (22%) 0.555 9%c,18
Hypertension 138 (41%) 82 (38%) 56 (47%) 0.120 62%d,19
Hypercholesterolaemia 118 (35%) 68 (31%) 50 (42%) 0.061 13%e
a 2011 National Census. Figures represent percentage of population aged over 40 years.
b Statistical Yearbook of Ireland 2012.
c Estimate is for persons over the age of 45 years and includes 6% with diagnosed and 3% undiagnosed diabetes.
d Estimate is for persons over the age of 45 years and includes 23% with diagnosed and 39% undiagnosed hypertension.
e Estimate based on personal communication estimate of 250,000 adults currently prescribed statins in Ireland.
Table 2. Risk factors, tobacco use and previous treatment of cardiovascular disease by sex, age and education proﬁle of study population.
Sex Age College education
Male (165) Female (171) 40e59 (175) 60 (161) Yes (107) No (229)
Risk factors
Hypertension 45% 37% 19% 65% 25% 48%
High cholesterol 40% 30% 22% 49% 23% 41%
Diabetes 30% 11% 10% 30% 12% 24%
Smoking
Current 16% 19% 23% 11% 15% 18%
Ex-smoker 47% 34% 38% 43% 42% 39%
Never smoked 37% 47% 39% 46% 43% 43%
Previous treatments
Heart attack 18% 8% 5% 21% 2% 17%
Stroke 12% 5% 6% 11% 8% 9%
Coronary angioplasty 17% 6% 4% 19% 7% 14%
Bold indicates p < 0.05 chi-square test for comparison of two proportions.
558 C.T. Cronin et al.“somewhat familiar” or “very familiar” with PAD were
better placed at recognizing the potential sequelae of PAD
and more likely to identify diabetes as a risk factor (Table 6).
Multivariate logistic regression analysis revealed that the
only independent predictor of awareness of PAD was having
undertaken a post-secondary-school course, with an odds
ratio (OR) of 4.2 (Table 7). Female patients (OR 1.69) and
those receiving treatment for hypertension or hyper-
cholesterolaemia (OR 2.02) showed a trend towards
increased awareness of PAD. Patients with known risk fac-
tors for PAD, such as smokers, diabetics, and patients with a
previous history of treatment for cardiovascular disease, did
not demonstrate any increased awareness of PAD.
DISCUSSION
Health advocacy is important in raising funds, lobbying for
better care, increasing public health knowledge, and patientempowerment. Certain diseases such as breast cancer have
very high levels of knowledge and advocacy. The ﬁve-year
survival rate for breast cancer in 2014 is approaching 85%
in contrast to severe PAD at 56%.3e5,8 Health advocates,
disease-speciﬁc voluntary associations, and the media work
for positive change in the health care system, improved
access to quality care, protection, and enhancement of
patient’s rights. Much of this is predicated on disease
awareness among patients, physicians, and the media as
well as politicians and policy-makers. Thus we sought to
evaluate awareness of PAD among the population.
This is the ﬁrst study in Ireland to assess public awareness
of PAD. The results clearly illustrate that self-reported
awareness of PAD in south-east Ireland is at a consider-
ably lower level than that of other vascular diseases. Largely
contributing to this low awareness is a lack of familiarity
with the term PAD, as well as the lack of an agreed, simple
Table 3. Awareness of cardiovascular and other diseases including PAD and AAA according to demographics of sex, age and education.
Sex Age College education
Male
(165)
Female
(171)
40e59
(175)
60
(161)
Yes
(107)
No
(229)
Cardiovascular
Stroke 91% 97% 97% 91% 94% 94%
PAD 16% 22% 19% 19% 34% 12%
AAA 18% 33% 27% 24% 43% 18%
Coronary artery disease 81% 75% 80% 76% 84% 75%
Other diseases
Diabetes 98% 99% 98% 98% 99% 98%
Multiple sclerosis 75% 79% 82% 71% 82% 74%
Bowel cancer 86% 87% 86% 87% 89% 85%
Note. Bold indicates p < 0.05 chi-square test for comparison of two proportions. AAA ¼ abdominal aortic aneurysm; PAD ¼ peripheral
artery disease.
Table 4. Perceived risk factors of PAD in study population.
Risk factor Sex Age College education
Male
(165)
Female
(171)
40e59
(175)
60
(161)
Yes
(107)
No
(229)
Being overweight 78% 81% 75% 84% 75% 81%
Smoking 87% 86% 80% 94% 82% 88%
Lack of exercise 81% 80% 76% 85% 77% 82%
Diabetes 65% 71% 69% 80% 73% 66%
Hypertension 69% 76% 68% 78% 71% 73%
High cholesterol 73% 79% 73% 80% 71% 78%
Myocardial infarction or stroke 67% 74% 69% 74% 66% 73%
Alcohol 65% 70% 66% 70% 67% 68%
Family history 66% 75% 67% 75% 66% 72%
Note. Bold indicates p < 0.05 chi-square test for comparison of two proportions. PAD ¼ peripheral artery disease.
For those not PAD aware a brief explanation of the condition was provided prior to posing this question.
Table 5. Potential sequelae of untreated peripheral artery disease as perceived by respondents.
Risk factor Sex Age College education
Male
(165)
Female
(171)
40e59
(175)
60
(161)
Yes
(107)
No
(229)
Stroke 67% 65% 60% 72% 64% 67%
Myocardial infarction 69% 64% 57% 78% 63% 69%
Death 68% 63% 56% 76% 62% 68%
Amputation 63% 57% 50% 71% 60% 60%
Inability to walk 73% 70% 58% 85% 64% 75%
Blood clot 70% 71% 58% 84% 63% 74%
Bold indicates p < 0.05 chi-square test for comparison of two proportions.
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and memorable. Internationally, the term peripheral artery
disease shortened to PAD is recommended for use both
scientiﬁcally and when communicating with the public.4,9,11
Low levels of public awareness of PAD have been demon-
strated in large population-based studies from the United
States (26% aware), Canada (36% aware), and Holland (20%
aware).2,4,11 Fewer than one in ﬁve of the population
questioned in Ireland was aware of PAD as a separate dis-
ease entity.
Our study population was broadly representative of the
general population based on those with prevalence of risk
factors for cardiovascular disease.20 Only 17% of the study
cohort were a current smoker, which is less than the pop-
ulation average of 21%. Smoking is the biggest risk factorfor PAD along with diabetes. A government anti-smoking
campaign in this country was successful in achieving a
smoking ban in public places in 2004, with support from the
Irish Heart Foundation, a national charity that provides
most of the education regarding heart disease and stroke.21
This may have contributed to the numbers of ex-smokers in
our cohort, which was 40%. One-third of the cohort had
third-level education, which is higher than reported 2006
ﬁgures, which record one-quarter of 45e75 year olds.22 The
fact that diabetics make up 20% of the group, compared
with the national estimate of prevalence of diabetes of 9%
in those over 45, reﬂects the fact that patients were
recruited mostly from hospital clinics. These patients and
those with post-secondary-school and third-level education
should, in theory, be more aware of PAD. The results are
Table 6. Correlation of self-reported awareness of PAD with sequelae and risk factors for PAD.
Not familiar with
PAD n ¼ 273
Somewhat familiar
with PAD n ¼ 52
Very familiar
with PAD n ¼ 11
p (chi-square)
Awareness of other diseases Stroke 93% 96% 91% .820
AAA 18% 50% 91% <.001
Potential sequelae of PAD? Inability to walk 68% 85% 82% .041
Amputation 56% 73% 91% .008
Risk factors for PAD Diabetes 64% 85% 91% .003
Smoking 84% 94% 100% .139
Being overweight 78% 83% 82% .764
Note. The percentages presented represent those participants with a positive response to the question: i.e. those that correctly identiﬁed
amputation as a sequelae of PAD or reported smoking as a risk factor contributing to the development of PAD. PAD ¼ peripheral artery
disease.
Table 7. Multivariate logistic regression of factors associated with increased awareness of peripheral artery disease.
Factor p Odds ratio 95% CI lower 95% CI upper
Age >60 years .856 1.06 0.54 2.10
Attended college <.001 4.60 2.49 8.51
Diabetes .458 0.73 0.31 1.69
Treatment for hypertension or
hypercholesterolaemia
.053 2.02 0.99 4.14
Female .092 1.69 0.92 3.11
Current smoker .886 0.94 0.43 2.08
Past history of cardiovascular illness .759 1.14 0.50 2.55
560 C.T. Cronin et al.even more alarming in light of this. The National Health
Service in the UK has produced clear management guide-
lines for PAD in terms of reducing the cost of amputation
including the use of risk factor modiﬁcation and medical
optimization. PAD is the single largest cause of lower limb
amputation in the UK. Implementation of these guidelines
in the UK could produce estimated savings as large as £1
million if there was only a 5% reduction in amputation (34
patients).23
Effect of awareness campaigns on cardiovascular disease
Awareness is important for both patients and physicians.We
must provide comprehensive education if patients are to
know to report symptoms to physicians and if physicians are
to perform ABIs on at-risk populations. Most patients with
PAD are asymptomatic yet share the same mortality risk as
symptomatic patients.7 Death rates from stroke and cardio-
vascular disease have signiﬁcantly reduced since they peaked
in the 1970s despite an increase in the prevalence of risk
factors such as obesity and diabetes.24 Public health educa-
tion programmes have been shown to improve knowledge
and awareness of cardiovascular disease and risk factors and
can account for some of the improved outcomes for cardio-
vascular disease.25e27 However, data on the impact of such
public health campaigns on improvements in clinically rele-
vant end points are scarce.27 Improvements in the diagnosis
and treatment of hypertension in Canada following a Cana-
dian Hypertension Education Program have served as one
example of the beneﬁts of such a campaign.28
In Ireland, the recent stroke awareness campaign utilizing
the FAST acronym to highlight stroke symptoms has resul-
ted in 70% of Irish adults now reporting the ability to
recognize stroke symptoms.21 The 1999 the “Legs For Life”screening and awareness programme administered by the
Society of Interventional Radiology reported short-term
improvements in awareness of PAD and management of
risk factors. The sustained, clinically important beneﬁts of
such a campaign have not yet been established.12
Epidemiology, risk factors, and targeted screening
In this studywe found that PAD awarenesswas lower in those
without post-secondary-school education in keeping with
other studies that have demonstrated the contribution of
lower socioeconomic status to increased risk of cardiovas-
cular disease.29,30 Establishing awareness of PAD in the
population at large may address this knowledge gap, linked
with a lower educational achievement.This could be included
with other health initiatives organized at government level
that have shown success.20,25,26 Smokers and diabetics are at
greatest risk of PAD, but none of these groups demonstrated
an increased recognition of PAD compared with those who
could be designated lower risk. Although most respondents
identiﬁed smoking correctly as being high risk, they similarly
cited obesity, lack of exercise, and alcohol as high risk,
probably demonstrating response bias or an amount of
guesswork despite no causal link with PAD. Respondent bias
towards knowledge of PAD, the fact that our cohort included
a higher rate of ex-smokers, diabetics, and people with
hypercholesterolaemia who should in theory be more versed
in knowledge of PAD, wouldmean that the primary ﬁnding of
a low level of awareness of PAD is, if anything, an over-
estimate. Targeting those most at risk of PAD in such a
screening intervention is important while the association
between conventional risk factors and the development of
PAD is well established, studies have shown that patients
with diagnosed PAD are less likely than those with coronary
Awareness of PAD 561artery disease to be treated with risk reduction strategies to
lower rates of myocardial infarction and stroke despite the
same risk factors underpinning the conditions.31e33
The World Health Organization has recommended
screening frameworks to suit available public budgets that
can be incorporated into public policy.34 Adequate training
must be completed in those undertaking ABIs as it is
operator dependent.
Limitations
This study provides an estimate of vascular disease aware-
ness. Owing to the profound lack of recognition of the term
PAD, and the absence of an equivalent well-known lay term,
it was necessary to give a basic explanation of the disease
using terms like “blocked arteries”, which people then un-
derstood, in order to facilitate the completion of the
questionnaire. We were unable to verify the accuracy of
self-reported medical conditions or leg symptoms in some
outpatient settings, as we did not access medical notes or
patient prescriptions for the study. We did not record any
antiplatelet use in our study, record smoking pack years, or
identify the motivation for our large number of ex-smokers,
which limited our analysis of these groups within our
cohort. All responses were based on self-reported patient
perception rather than a formal assessment of knowledge
resulting in recall bias. Despite a large sample size and in-
clusion of members of the public in our study, further
studies of a wider population are necessary to assess reli-
ability and potential selection bias. This cohort had a higher
than population average of respondents with diabetes and
hypercholesterolaemia and a high number of ex-smokers,
emphasizing the fact that even in an at-risk population
awareness of PAD was low.
CONCLUSION
This study demonstrates a disturbing lack of awareness of
PAD and highlights the need for a meaningful targeted
public health awareness campaign on PAD in order to close
the gap of knowledge in Irish patients. Education regarding
the terminology of PAD is a key element in increasing dis-
ease awareness.
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